(PHAT)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
Phathom Pharmaceuticals, Inc., biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda oshqozon-ichak kasalliklarini davolashni ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniya VOQUEZNAni ishlab chiqadi, bu kattalarda eroziyali gastroezofageal reflyuks kasalligi (GERD) va tegishli ko'krak qafasidagi yonishni davolash bo'yicha III bosqich klinik sinovlarini yakunlagan; va kattalarda va o'smirlarda Helicobacter pylori davolash bo'yicha III bosqich klinik sinovlarini yakunlagan VOQUEZNA Triple Pak va VOQUEZNA Dual Pak, shuningdek, kattalar va o'smirlarda eroziyali bo'lmagan GERD va eozinofilik ezofagit bilan bog'liq ko'krak qafasidagi yonishni davolash uchun VOQUEZNA va vonoprazan. Kompaniya 2018-yilda tashkil etilgan va Florham Park, Nyu-Jersi shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Azmi Nabulsi M.D., M.P.H. | Co-Founder |
| Mr. Bill Aprea J.D. | Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer |
| Mr. David A. Socks | Co-Founder |
| Mr. Eric Sciorilli | Director of Business Development & Investor Relations |
| Mr. Jonathan Bentley | Senior VP and Head of Sales, Operations & Training |
| Mr. Paul Cocja | Chief People Officer |
| Mr. Robert Breedlove | VP of Finance & Principal Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2025-11-04 | 8-K | d20656d8k.htm |
| 2025-10-30 | 10-Q | phat-20250930.htm |
| 2025-10-27 | 8-K | d62248d8k.htm |
| 2025-10-06 | 8-K | d76139d8k.htm |
| 2025-08-07 | 10-Q | phat-20250630.htm |
| 2025-06-16 | 8-K | d924090d8k.htm |
| 2025-06-09 | 8-K | d95460d8k.htm |
| 2025-06-06 | 8-K | d941196d8k.htm |
| 2025-05-01 | 10-Q | phat-20250331.htm |
| 2025-04-23 | DEFA14A | phat-20250422.htm |
| Mr. Sanjeev Narula |
| Chief Financial & Business Officer |
| Mr. Steven L. Basta M.B.A. | CEO, President & Director |
| Ms. Anne Marie Cook Esq., J.D. | Chief Legal Officer & Corporate Secretary |